Sep 30, 2026
Novo Nordisk (NVO) Stock: Oral Wegovy Users Drop 4% Body Weight in New Study
Novo Nordisk (NVO) OCTANE study shows patients switching to oral Wegovy lost 4.1% body weight in 3 months, with obesity rates dropping significantly.
The post Novo Nordisk (NVO) Stock: Oral Wegovy Users Drop 4% Body Weight in New Study appeared first on Blockonomi.
Source: Blockonomi →Related News
- 57 minutes ago
UNI Wallet Creation Reaches Highest Level Since November 2022
- 1 hour ago
Rocket Lab (RKLB) Stock: Surges as Electron Completes 98th Launch for HawkEye 36...
- 4 hours ago
Cosmos (ATOM) Price Prediction: Can ATOM Reach $15?
- 4 hours ago
XRP News: Why Korea’s KYC-Ready Traders Could Fast-Track XRP Tokenization
- 7 hours ago
Robinhood sees surge in bitcoin, gold prediction markets as traders move beyond...